Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation

Blood

Volumn 102, Issue 1, 2003, Pages 394-403

  Wells, Denise A ^a   Benesch, Martin ^b   Loken, Michael R ^b   Vallejo, Carlos ^b   Myerson, David ^b   Leisenring, Wendy M ^b   Deeg, H Joachim ^b  

^a HEMATOLOGICS INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOTRANSPLANTATION; ARTICLE; BLAST CELL; BLOOD CELL COUNT; BONE MARROW CELL; CELL STRUCTURE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; MYELOPOIESIS; NEUTROPHIL; OUTCOMES RESEARCH; PARAMETER; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 0038578247     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-09-2768     Document Type: Article

References (50)

1. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079-2088.
2. Terstappen LW, Safford M, Konemann S, et al. Flow cytometric characterization of acute myeloid leukemia, part II: phenotypic heterogeneity at diagnosis. Leukemia. 1992;6:70-80.
3. Wells DA, Hall MC, Shulman HM, Loken MR. Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias. Leukemia. 1998;12:2015-2023.
4. Wells DA, Sale GE, Shulman HM, et al. Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. Am J Clin Pathol. 1998;110:84-94.
5. Sievers EL, Lange BJ, Buckley JD, et al. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. J Natl Cancer Inst. 1996;88:1483-1488.
6. Kristensen JS, Hokland P. Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes. Br J Haematol. 1990;74:270-276.
7. Hilbe W, Eisterer W, Schmid C, et al. Bone marrow lymphocyte subsets in myelodysplastic syndromes. J Clin Pathol. 1994;47:505-507.
8. Mittelman M, Karcher DS, Kammerman LA, Lessin LS. High Ia (HLA-DR) and low CD11b (Mol) expression may predict early conversion to leukemia in myelodysplastic syndromes. Am J Hematol. 1993;43:165-171.
9. Loken MR, Wells DA. Normal antigen expression in hematopoiesis: basis for interpreting leukemia phenotypes. In: Stewart CC NJ, ed. Immunophenotyping. New York, NY: Wiley-Liss; 2000:133-160.
10. Wormann B, Drescher M, Safford M, et al. Identification of Mds and secondary Aml by light scattering properties [meeting abstract]. Proc Annu Meet Am Assoc Cancer Res. 1992;33:A1263.
11. Bowen KL DB. Abnormal patterns of expression of CD16 (FcR-III) and CD11b (CRIII) antigens by developing neutrophils in the bone marrow of patients with myelodysplastic syndrome. Lab Hematol. 1997;3:292-298.
12. Stetler-Stevenson M, Arthur DC, Jabbour N, et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood. 2001;98:979-987.
13. Maynadie M, Picard F, Husson B, et al. Immunophenotypic clustering of myelodysplastic syndromes. Blood. 2002;100:2349-2356.
14. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
15. Deeg HJ, Appelbaum FR. Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. Leuk Res. 2000;24:653-663.
16. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
17. Greenberg PL. Risk factors and their relationship to prognosis in myelodysplastic syndromes. Leuk Res. 1998;22(suppl 1):S3-S6.
18. Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci. 1993;677:265-280.
19. Owens M, Loken M. Flow Cytometry Principles for Clinical Laboratory Practice: Quality Assurance for Quantitiative Immunophenotyping. New York, NY: Wiley-Liss; 1995.
20. Terstappen L, Shah V, Civin C, Hurwitz C, Loken M. Multidimensional flow cytometry as a new approach for discrimination between normal and leukemic cells in peripheral blood and bone marrow. In: Jansen A, ed. Progress in Cytometry II: Flow and Image. Erembodegen, Belgium: Becton-Dickinson; 1989:4-29.
21. Terstappen LW, Loken MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol. 1990;2:229-240.
22. Loken M. Multidimensional data analysis in immunophenotyping. In: Robinson P, ed. Current Protocols on CD-ROM. New York, NY: Wiley-Liss; 1997.
23. Terstappen LW, Shah VO, Conrad MP, Recktenwald D, Loken MR. Discriminating between damaged and intact cells in fixed flow cytometric samples. Cytometry. 1988;9:477-484.
24. Borowitz MJ, Guenther KL, Shults KE, Stelzer GT. Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol. 1993;100:534-540.
25. Rainer R, Hodges L, Stelzer G. CD45 gating correlates with bone marrow differential. Cytometry. 1995;22:139-145.
26. Shah VO, Civin CI, Loken MR. Flow cytometric analysis of human bone marrow, IV: differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis. J Immunol. 1988;140:1861-1867.
27. Terstappen LW, Safford M, Loken MR. Flow cytometric analysis of human bone marrow, III: neutrophil maturation. Leukemia. 1990;4:657-663.
28. Terstappen LW, Hollander Z, Meiners H, Loken MR. Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukoc Biol. 1990;48:138-148.
29. Loken M, Terstappen L, Civin C, Fackler M. Flow cytometric characterization of erythroid, lymphoid, and monomyeloid lineages in normal human bone marrow. In: Laerum O, Bjerksnes R, eds. Flow Cytometry in Hematology. New York, NY: Academic Press; 1992:31-42.
30. Terstappen LW, Konemann S, Safford M, et al. Flow cytometric characterization of acute myeloid leukemia, Part 1: significance of light scattering properties. Leukemia. 1991;5:315-321.
31. Terstappen LW, de Grooth BG, van Berkel W, ten Napel CH, Greve J. Application of orthogonal light scattering for routine screening of lymphocyte samples. Cytometry. 1988;9:220-225.
32. de Haas M, Kleijer M, vanZwieten R, Roos D, von dem Borne A. Neutrophil FcRIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood. 1995;86:2403-2413.
33. Kwong YL, Lee CP, Chan TK, Chan LC. Flow cytometric measurement of glycosylphosphatidyl-inositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal hemoglobinuria. Am J Clin Pathol. 1994;102:30-35.
34. Peiper SC, Ashmun RA, Look AT. Molecular cloning, expression, and chromosomal localization of a human gene encoding the CD33 myeloid differentiation antigen. Blood. 1988;72:314-321.
35. Favaloro EJ, Bradstock KF, Kabral A, Grimsley P, Berndt MC. Characterization of monoclonal antibodies to the human myeloid-differentiation antigen, 'gp67'(CD-33). Dis Markers. 1987;5:215-225.
36. Favaloro EJ, Bradstock KF, Kabral A, Grimsley P, Zowtyj H, Zola H. Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33. Br J Haematol. 1988;69:163-171.
37. Hurwitz CA, Mirro J Jr. Mixed-lineage leukemia and asynchronous antigen expression. Hematol Oncol Clin North Am. 1990;4;767-794.
38. Greaves MF, Chan LC, Furley AJ, Watt SM, Molgaard HV. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood. 1986;67:1-11.
39. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
40. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295-304.
41. Deeg HJ, Storer B, Slattery JT, et al. Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood. 2002;100:1201-1207.
42. Goerner M, Gooley T, Flowers ME, et al. Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biol Blood Marrow Transplant. 2002;8:47-56.
43. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4:87-90.
44. Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc. 1958;53:457-461.
45. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: Wiley; 1980.
46. Nevill TJ, Fung HC, Shepherd JD, et al. Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation. Blood. 1998;92:1910-1917.
47. Terstappen LW, Safford M, Unterhalt M, et al. Flow cytometric characterization of acute myeloid leukemia, IV: comparison to the differentiation pathway of normal hematopoietic progenitor cells. Leukemia. 1992;6:993-1000.
48. Otawa M, Kawanishi Y, Iwase O, Shoji N, Miyazawa K, Ohyashiki K. Comparative multicolor flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia. Leuk Res. 2000;24:359-366.
49. Corash L, Levin J, Mok Y, Baker G, McDowell J. Measurement of megakaryocyte frequency and ploidy distribution in unfractionated murine bone marrow. Exp Hematol. 1989;17:278-286.
50. Law HK, Bol SJ, Palatsides M, Williams NT. Analysis of human megakaryocytic cells using dual-color immunofluorescence labeling. Cytometry. 2000;41:308-315.